Clinical characterization of patients with SCD used in the PLA assay
| Female/male | 6/4 |
| Age (y) | 41.40 (41; 30-61) |
| Red blood cells (×103/μL) | 2.82 (2.55; 1.92-4.8) |
| Hemoglobin (g/dL) | 9.52 (9.65; 6.8-13.7) |
| Hematocrit (%) | 27.37 (28.55; 19.6-37.7) |
| White blood cells (×103/μL) | 8.69 (7.35; 3.2-13.2) |
| % neutrophils | 56.38 (58.3; 39-72) |
| % lymphocytes | 26.09 (21.75; 8-49) |
| % monocytes | 8.9 (9.45; 1.4-14) |
| Platelets (×103/μL) | 360.2 (308.5; 113-860) |
| % HbF | 13.51 (9.75; 1.5-35.4) |
| SCD genotype | |
| SS | 8 |
| S/β0 | 1 |
| SC | 1 |
| Hydroxyurea (yes/no) | 6/4 |
| Female/male | 6/4 |
| Age (y) | 41.40 (41; 30-61) |
| Red blood cells (×103/μL) | 2.82 (2.55; 1.92-4.8) |
| Hemoglobin (g/dL) | 9.52 (9.65; 6.8-13.7) |
| Hematocrit (%) | 27.37 (28.55; 19.6-37.7) |
| White blood cells (×103/μL) | 8.69 (7.35; 3.2-13.2) |
| % neutrophils | 56.38 (58.3; 39-72) |
| % lymphocytes | 26.09 (21.75; 8-49) |
| % monocytes | 8.9 (9.45; 1.4-14) |
| Platelets (×103/μL) | 360.2 (308.5; 113-860) |
| % HbF | 13.51 (9.75; 1.5-35.4) |
| SCD genotype | |
| SS | 8 |
| S/β0 | 1 |
| SC | 1 |
| Hydroxyurea (yes/no) | 6/4 |
Data show mean (median; range) except for the sex and hydroxyurea status.
HbF, fetal hemoglobin; S/β0, sickle β0-thalassemia; SC, hemoglobin SC disease; SS, sickle cell anemia.